Latest metoclopramide Stories

Approval Follows Recent Launch of Generic Prefilled Injectables FRANKLIN LAKES, N.J., April 23, 2013 /PRNewswire/ -- BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE:BDX), announced today that the U.S. Food and Drug Administration (FDA) has approved the second drug to be offered in the recently launched BD Simplist(TM) line of ready-to-administer prefilled generic injectables. The second BD Simplist product...

Mr. Schulte Prevails on Behalf of Alleged Victim of Generic Metoclopromide, as Sixth Circuit Allows State Law Failure to Warn Claim to Proceed Against Pliva, Inc. Dayton, OH (PRWEB) April 18, 2013 Richard W. Schulte, a partner with the experienced drug injury firm of Wright & Schulte LLC, continues his fight on behalf of victims of generic drug injuries, the Firm reports. On March 14th, the Sixth Circuit Court of Appeals ruled that a woman being represented by Richard Schulte could...

According to court documents, on March 7th, 2013 a Louisiana woman asked the US Supreme Court to hear her case alleging neurological damage from generic Reglan. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Reglan side effects. San Diego, CA (PRWEB) March 26, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently...

According to court documents, on December 10th, 2012, a Michigan man filed a products liability claim at Philadelphia Court of Common Pleas alleging he suffered tardive dyskinesia from his use of Reglan. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Reglan side effects. [http://www.attorneyone.com/reglan-lawsuit/ San Diego, CA (PRWEB)...

According to court documents, on May 29th, 2012, a Minnesota woman, Marilyn Abicht, filed a lawsuit in Minnesota District Court (case no. 0:2012cv01278) alleging that Reglan (metoclopramide) caused her tardive dyskinesia. Reglan (metoclopramide) is a drug used to help with the digestive process and reduce the symptoms of acid reflux and heartburn. It has been in the market since 1996. In 2009, the US FDA issued a black box warning that treatment with metoclopramide (Reglan) can cause...

CAMBRIDGE, England, May 28, 2012 /PRNewswire/ -- Acacia Pharma announces positive results from its Phase II study of APD421, in the prevention of post-operative nausea & vomiting (PONV). The study showed that APD421 significantly reduced the incidence of nausea and vomiting compared to placebo in adult surgical patients at moderate-to-high risk of suffering PONV. Vomiting and especially nausea remain a major problem for patients after surgical operations, despite the...

WASHINGTON, June 23, 2011 /PRNewswire/ -- The following statement is being issued by Ralph Pittle, legal director of The Conte Foundation. Today's Supreme Court ruling in Pliva v. Mensing that freed generic makers of the drug Reglan from liability for failing to alert the FDA of new risks places the responsibility back where it belongs with Wyeth, the company that plaintiffs allege in thousands of lawsuits before the courts knowingly misled doctors about its safety when bringing the drug to...

WASHINGTON, June 20, 2011 /PRNewswire/ -- The U.S. Supreme Court is expected to rule shortly on whether generic drug companies must adequately warn doctors about new or revised risks to patients who have taken the drugs they make. (Pliva v Mensing No. 09-993, Actavis v Mensing No.08-3850 and Actavis v Demahy No. 09-1501) All three cases involve patients who took metoclopramide, the generic version of the brand-name drug Reglan. An estimated 10,000 Reglan-metoclopramide lawsuits would be...

ATLANTA, July 19 /PRNewswire/ -- The law firm of Childers, Schlueter & Smith, LLC of Atlanta, Georgia has announced that a jury trial involving the drug Reglan/metoclopramide will be held during the week of July 26, 2010. The case is Susan Swicegood v. Pliva et. al. in the United States District Court, Northern District of Georgia, Atlanta Division. The lawsuit alleges that the drug makers and marketers of Reglan/metoclopramide failed to adequately warn physicians of the long-term...

Reglan, metoclopramide never approved for use in infants HOUSTON, May 3 /PRNewswire-USNewswire/ -- Recently, researchers have observed a disturbing trend in neonatal units across the country: doctors prescribing Reglan -- also known by its generic name, metoclopramide -- to treat premature infants. This alarming development has raised serious concerns from many consumer safety advocates, particularly because the drug was never approved for use in infants. Reglan (metoclopramide) was...